Figure 2From: Clinicopathologic study of E-cadherin/beta-catenin complex, and topoisomerase-II in a series of 71 liposarcoma casesa) Area of extremity liposarcoma with moderate expression of topoisomerase IIa (21-50% of neoplastic cells showed nuclear immunoreactivity ( arrow ) (DAB X400). b) Weak expression of topoisomerase IIa in extremity liposarcoma (< 20% of neoplastic cells showed nuclear immunoreactivity (arrow) (DAB X400).Back to article page